Eli Lilly

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Eli Lilly 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. 

CEO
David A. Ricks
CEODavid A. Ricks
Employees
50,000
Employees50,000
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1876
Founded1876
Employees
50,000
Employees50,000

LLY Key Statistics

Market cap
940.72B
Market cap940.72B
Price-Earnings ratio
35.60
Price-Earnings ratio35.60
Dividend yield
0.63%
Dividend yield0.63%
Average volume
3.89M
Average volume3.89M
High today
$991.00
High today$991.00
Low today
$973.00
Low today$973.00
Open price
$985.00
Open price$985.00
Volume
200.16K
Volume200.16K
52 Week high
$1,133.95
52 Week high$1,133.95
52 Week low
$623.78
52 Week low$623.78

Stock Snapshot

Eli Lilly(LLY) stock is priced at $977.77, giving the company a market capitalization of 940.72B. It carries a P/E multiple of 35.60 and pays a dividend yield of 63.0%.

On 2026-05-07, Eli Lilly(LLY) stock traded between a low of $973.00 and a high of $991.00. Shares are currently priced at $977.77, which is +0.5% above the low and -1.3% below the high.

The Eli Lilly(LLY)'s current trading volume is 200.16K, compared to an average daily volume of 3.89M.

In the last year, Eli Lilly(LLY) shares hit a 52-week high of $1,133.95 and a 52-week low of $623.78.

In the last year, Eli Lilly(LLY) shares hit a 52-week high of $1,133.95 and a 52-week low of $623.78.

LLY News

TipRanks 2h
Centessa Sets June Vote on $38-Per-Share Eli Lilly Takeover with Added CVR Upside

New activity is brewing for Centessa Pharmaceuticals ( (CNTA) ). The company has submitted a Form DEFM14A to the SEC, indicating an upcoming shareholder vote. T...

Zacks 4h
The Zacks Analyst Blog Highlights Eli Lilly, Western Digital, Vertiv Holdings and AgEagle

We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. By pressing "Accept All...

The Zacks Analyst Blog Highlights Eli Lilly, Western Digital, Vertiv Holdings and AgEagle
The Wall Street Journal 4h
America’s Weight-Loss Drug Boom Is Going Global

Markets outside the U.S. hold huge potential for weight-loss drugs such as Wegovy. George Frey / Bloomberg News As the weight-loss category grows more competit...

America’s Weight-Loss Drug Boom Is Going Global

Analyst ratings

85%

of 33 ratings
Buy
84.8%
Hold
12.1%
Sell
3%

More LLY News

TipRanks 5h
Eli Lilly Raises Bet to $21B as Obesity Pill War with Novo Nordisk Intensifies

U.S. pharma giant Eli Lilly (LLY) has pumped another $4.5 billion investment into its manufacturing facilities in Indiana, a key anchor of its domestic manufact...

Nasdaq 5h
My Top Obesity Stock to Buy and Hold

Key Points Eli Lilly's Zepbound is already generating billions of dollars in revenue, making it the clear leader in a rapidly expanding market. Lilly’s abilit...

My Top Obesity Stock to Buy and Hold
Benzinga 5h
Eli Lilly To Invest $4.5 Billion More In Indiana Manufacturing Sites

The additional funding is intended to support the production of Foundayo, Lilly’s newly approved weight-loss pill, and retatrutide, an obesity treatment in late...

Eli Lilly To Invest $4.5 Billion More In Indiana Manufacturing Sites
Simply Wall St 6h
Eli Lilly Indiana Expansion Supports Obesity Pipeline And Undervalued Story

Eli Lilly (NYSE:LLY) is committing $4.5b to expand its Indiana manufacturing footprint. The investment includes the Lebanon Advanced Therapies facility, the co...

Eli Lilly Indiana Expansion Supports Obesity Pipeline And Undervalued Story
TipRanks 9h
Eli Lilly commits additional $4.5B across Indiana manufacturing sites

Eli Lilly (LLY) and Company announced an additional $4.5B investment across two of its three Lebanon sites-bringing the company’s total Indiana capital expansio...

TipRanks 11h
Trump Highlights Eli Lilly’s $4.5 Billion Genetic Medicine Push: Potential Ripple Effects Across Health Care and Biotech ETFs - TipRanks

...

Trump Highlights Eli Lilly’s $4.5 Billion Genetic Medicine Push: Potential Ripple Effects Across Health Care and Biotech ETFs - TipRanks
Barron's 1d
Novo Stock Rises After Earnings. It’s Taking the Weight-Loss Drug Fight to Eli Lilly.

Biotech and Pharma Earnings Report Novo Stock Rises After Earnings. It’s Taking the Weight-Loss Drug Fight to Eli Lilly. In this article NVO LLY Novo Nordisk ra...

Novo Stock Rises After Earnings. It’s Taking the Weight-Loss Drug Fight to Eli Lilly.

People also own

Based on the portfolios of people who own LLY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.